The 2026 Medicare Part D out-of-pocket cap now sits at $2,100, a $100 increase from the $2,000 cap that took effect in 2025. That single number protects every Medicare beneficiary from runaway drug costs, replacing a system where beneficiaries faced far higher out-of-pocket spending before reaching catastrophic coverage under the old benefit structure. A cap alone doesn’t guarantee smart use of a benefit, though.
Making the right mid-year adjustments to a prescription strategy, checking a plan’s formulary, and preparing early for the changes CMS has planned for 2027 can be the difference between a predictable healthcare budget and paying more than necessary. Whether prescription coverage comes from a standalone Part D plan or is built into a Medicare Advantage plan, this guide walks through what changed in 2026, how to check in on coverage after tax season, and what to do now to get ahead of next year’s adjustments.
Understanding the 2026 Part D Out-of-Pocket Cap
CMS’s redesign of the Part D benefit eliminated the old coverage gap phase, commonly known as the donut hole, and replaced it with a three-phase structure consisting of a deductible phase, an initial coverage phase, and a catastrophic phase. Once a beneficiary’s true out-of-pocket costs for covered medications reach $2,100 in 2026, the plan pays 100% of covered drug costs for the remainder of the calendar year.
The $2,100 figure for 2026 is the original $2,000 cap from 2025, adjusted upward based on the annual growth in average Part D drug spending, so the increase reflects a built-in inflation formula rather than a policy rollback. It’s worth noting this cap applies only to drug costs. Medicare supplement plans, which help with hospital and doctor coinsurance under Original Medicare, don’t include drug coverage on their own and work alongside a separate Part D policy.
The Three-Phase Drug Benefit and Why Timing Matters
Coverage in 2026 moves through three phases. Beneficiaries first satisfy any plan deductible, then pay coinsurance on covered drugs during the initial coverage phase, and finally reach catastrophic coverage once out-of-pocket spending hits $2,100. Because there’s no separate coverage gap phase left to navigate, tracking spending across the year is simpler than it used to be, but timing still matters.
Beneficiaries with variable prescription needs may benefit from the Medicare Prescription Payment Plan, which lets enrollees spread out-of-pocket drug costs into predictable monthly installments instead of paying larger amounts at the pharmacy counter. A licensed medicare agent can walk through whether this option makes sense for a specific household’s prescription pattern.
Making Mid-Year Adjustments to Your Prescription Coverage
Spring and early summer are an underused window for reviewing prescription coverage. Right after tax season is a natural time to pull the year’s benefit statements and see how close a household is tracking toward the $2,100 cap.
Adjustments at this point can include switching to a preferred pharmacy within the plan’s network, asking a doctor about generic or therapeutic alternatives that cost less, or enrolling in the Prescription Payment Plan if a beneficiary hasn’t already reached catastrophic coverage but expects high costs later in the year. It’s also worth checking whether a plan’s formulary changed since January, since plans can adjust which drugs are covered and at what tier throughout the year. Catching a formulary shift in June rather than discovering it at the pharmacy in November avoids both frustration and unnecessary cost.
Reading Your EOB: The Fastest Way to Know Where You Stand
The quickest way to make an informed decision midyear is to actually read the paperwork already showing up in the mail. Part D plans send an explanation of benefits after a pharmacy bills the plan, and this document is not a bill. Plans offering both medical and drug coverage together, such as Medicare Advantage plans, generally bundle Part A, Part B, and usually Part D coverage into one plan, so beneficiaries in these plans see the same kind of monthly cost detail reflected in their statements. Checking a few months side by side is often the clearest way to see whether spending is tracking toward the $2,100 cap faster or slower than expected.
Extra Help and Other Assistance Programs Worth a Second Look
Beneficiaries with limited income and resources may qualify for the Part D Low-Income Subsidy, which can waive premiums and deductibles entirely and reduce copays for covered drugs. Many people assume their income is too high to qualify, but the income and resource limits are often more generous than expected, and eligibility can change year to year as income shifts in retirement. This is also a good time to ask about Medicare supplemental insurance plans more broadly, since some beneficiaries assume Extra Help and supplemental insurance are mutually exclusive when they aren’t.
How Medicare Advantage Plans Factor Into Your Drug Strategy
Many beneficiaries get prescription coverage automatically through Medicare Advantage rather than a standalone Part D policy. CMS coordinates payment policy for Medicare Advantage and Part D together each year, which is why the same $2,100 out-of-pocket structure applies whether drug coverage is bundled into a Medicare Advantage plan or purchased as a stand-alone policy. Medicare Advantage plans frequently combine $0 premiums with built-in drug coverage, dental, vision, and hearing benefits that Original Medicare doesn’t include on its own. Reviewing how a plan’s drug formulary and pharmacy network line up with a household’s actual prescriptions is one of the most valuable mid-year adjustments a beneficiary can make.
The $35 Insulin Cap Still Applies in 2026
Beneficiaries managing diabetes have an added layer of protection built into the 2026 benefit. Under the Inflation Reduction Act, out-of-pocket costs for covered insulin products are capped at $35 for each monthly prescription under Part D, a protection that has been in place since January 2023 and carries forward into 2026 alongside the new $2,100 overall cap. The cap applies per insulin product, so a beneficiary using two different types, such as a long-acting basal insulin and a rapid-acting mealtime insulin, could pay up to $35 for each one rather than $35 total.
No deductible applies to insulin either, meaning the $35 cap holds even before a beneficiary has met the rest of their plan’s yearly deductible. The same $35 monthly limit extends to insulin delivered through a traditional pump under Part B, so the protection follows a beneficiary regardless of which part of Medicare covers their specific insulin delivery method.
For households managing diabetes alongside several other prescriptions, this cap is worth factoring into any mid-year review, since predictable insulin costs make it easier to forecast how quickly the rest of the year’s spending will approach the $2,100 ceiling.
Looking Ahead: Preparing for 2027 CMS Benefit Adjustments
CMS has already signaled changes coming in 2027. The agency will discontinue its temporary premium stabilization demonstration at the end of 2026, returning stand-alone Part D pricing to standard market conditions, with the national base beneficiary premium rising to $41.33. Separately, CMS has finalized negotiated prices for 15 additional high-cost medications under the second cycle of the Medicare Drug Price Negotiation Program, with the new prices taking effect January 1, 2027. None of these changes require action today, but working with a Medicare agency now means being far better positioned during fall Open Enrollment to compare plans and decide whether current coverage still fits.
Don’t Skip the Annual Notice of Change Letter
Every fall, plans send an Annual Notice of Change letter that spells out exactly how coverage and costs will shift starting January 1. This letter typically arrives by the end of September, ahead of the Annual Enrollment Period, and it covers premium changes, updated deductibles, revised formularies, and any additions or removals to a plan’s pharmacy and provider network. Reading it closely, ideally right when it arrives rather than waiting until December, gives beneficiaries a real head start heading into 2027 and pairs naturally with any mid-year adjustments already made earlier in the year.
Avoiding the Part D Late Enrollment Penalty
Anyone weighing whether to delay enrollment should understand how the penalty works. Medicare charges a permanent penalty for every month a beneficiary goes without Part D or other creditable coverage once they’ve gone 63 days or more without it. The penalty is calculated as 1% of the national base beneficiary premium, which is $38.99 for 2026, for each month of delay, and it’s added to the monthly premium for as long as the beneficiary carries Part D coverage. The penalty doesn’t apply to those with creditable coverage through an employer, union, TRICARE, or certain other sources, or to those receiving Extra Help.
Where to Get Free, Unbiased Help Comparing Plans
Reviewing formularies, cost tiers, and eligibility rules on your own can feel overwhelming, and beneficiaries don’t have to do it alone. The State Health Insurance Assistance Program is a federally funded counseling service available in every state, including Texas, and it offers one-on-one guidance at no cost to the beneficiary. Counselors are not affiliated with any insurance company and don’t sell plans, so their guidance is strictly unbiased. That kind of neutral, no-cost resource pairs well with sitting down with health insurance agents who know the actual plans available where you live.
Appointments can typically be scheduled by phone or online, and most sessions run about an hour, plenty of time to walk through a specific list of medications and compare it against a few plan options. Beneficiaries don’t need to bring anything more than their Medicare card and a current list of prescriptions to get useful, personalized answers. This is because counselors see plan changes across the entire state each year; they’re often quick to flag a formulary shift or premium increase that a beneficiary might otherwise miss until the bill arrives.
Let Medicare4USA Help You Navigate Your 2027 Prescription Strategy
We at Medicare4USA help Medicare beneficiaries make sense of exactly this kind of change every year. As a medicare agent with more than 28 years of experience, we walk clients through Part D options, Medicare Advantage, and medicare supplement coverage side by side, so mid-year adjustments and 2027 planning conversations never have to happen alone. Beyond Medicare, we also help families with group health insurance and individual health insurance for household members who aren’t yet Medicare-eligible. We travel directly to your home or another location that’s convenient for you, since we don’t operate out of a traditional office, and we’re proud to serve every member of our community. If your prescription costs have changed this year or you want a head start on 2027, reach out to Medicare4USA and let’s build a strategy together.